36 studies found for:    Open Studies | "Platelet Aggregation Inhibitors"
Show Display Options
Rank Status Study
1 Unknown  Plavix, Prasugrel and Drug Eluting Stents Pilot Trial
Conditions: Coronary Artery Disease;   Platelet Aggregation Inhibitors;   PCI- Percutaneous Coronary Intervention
Interventions: Drug: Loading Dose Arm;   Drug: Maintenance Dose Arm
2 Unknown  Determining Genetic Role in Treatment Response to Anti-Platelet Interventions (The PAPI Study)
Conditions: Platelet Aggregation Inhibitors;   Coronary Heart Disease
Interventions: Drug: Clopidogrel;   Drug: Aspirin
3 Recruiting Cost-effectiveness of Genotype Guided Treatment With Antiplatelet Drugs in STEMI Patients: Optimization of Treatment
Conditions: Myocardial Infarction;   STEMI
Intervention: Genetic: CYP2C19 genotyping
4 Recruiting Research of Resistance to Antiplatelet Agents and Development of Tailored Treatment Model for Patients With Coronary Artery Disease
Conditions: Cardiovascular Diseases;   Coronary Artery Disease
Intervention:
5 Recruiting Compare the Efficacy of Different Antiplatelet Therapy Strategy After Coronary Artery Bypass Graft Surgery
Conditions: Coronary Artery Bypass;   Antiplatelet Agents
Interventions: Drug: Aspirin;   Drug: Ticagrelor
6 Recruiting Comparative Pharmacodynamics and Pharmacokinetics Study of Generic and Reference Clopidogrel Products
Condition: Antiplatelet Agents
Interventions: Drug: Generic clopidogrel product Apolets®;   Drug: Original clopidogrel product Plavix®
7 Recruiting Ticagrelor and Endothelial Function
Condition: Antiplatelet Agents; Endothelial Function; Pleotropic Effects
Interventions: Drug: ticagrelor;   Drug: prasugrel
8 Recruiting Clopidogrel And Ticagrelor in Healthy Subjects
Condition: Pharmacodynamics of Antiplatelet Agent.
Interventions: Drug: Ticagrelor 90 mg;   Drug: Clopidogrel 600 mg
9 Recruiting BLeeding Events and Maintenance DoSe of PraSugrel
Conditions: Adverse Reaction to Antiplatelet Agent;   Acute Coronary Syndrome
Interventions: Drug: Prasugrel dose 5 mg/day;   Drug: Prasugrel dose 10 mg/day
10 Recruiting Mojito Study (Mashed Or Just Integral Pill of TicagrelOr ? )
Conditions: Acute Coronary Syndrome;   Adverse Reaction to Antiplatelet Agent
Interventions: Drug: Ticagrelor mashed pills;   Drug: Ticagrelor integral pills
11 Unknown  Evaluation of Antiplatelet Drug Resistance in Taiwanese With VASP & Platelet Mapping ™ Assay
Condition: 30 Healthy People
Intervention: Drug: Clopidogrel and proton pump inhibitors
12 Recruiting Prevention of Cardiovascular Events by Antiplatelet Agents After Acute Coronary Syndrome
Condition: Acute Coronary Syndrome
Intervention:
13 Recruiting Bedside Testing of CYP2C19 Gene for Treatment of Patients With PCI With Antiplatelet Therapy
Conditions: Coronary Artery Disease;   Myocardial Infarction;   Heart Disease;   Vascular Disease;   Angina Pectoris;   Cardiovascular Disease;   Ischemia;   Infarction;   Embolism;   Thrombosis;   Chest Pain
Interventions: Drug: clopidogrel;   Drug: Ticagrelor or prasugrel
14 Recruiting Platelet Transfusion in Acute Intracerebral Hemorrhage
Condition: Intracerebral Hemorrhage
Intervention: Biological: platelets
15 Unknown  rFVIIa in ICH in Patients Treated With Anticoagulants or Anti-Platelets
Condition: Intracerebral Hemorrhage
Interventions: Drug: rFVIIa + (vit K in AO patients);   Drug: FFP or aPCC+ vit K in AO treated patients
16 Recruiting Drug Drug Interactions of Aspirin and P2Y12-inhibitors
Conditions: VA Drug Interactions [VA Drug Interaction];   Myocardial Infarction
Interventions: Drug: Morphine;   Drug: Placebo
17 Not yet recruiting Standard Clopidogrel Versus Prasugrel Low Dose Therapy in Elderly Patients With Acute Coronary Syndrome
Condition: Coronary Artery Disease
Interventions: Drug: Clopidogrel;   Drug: Prasugrel
18 Recruiting Platelet Function in Patients With an Acute Coronary Syndrome
Condition: Acute Coronary Syndrome (ACS)
Intervention:
19 Recruiting Antiplatelet Therapy for Patients Undergoing Transcatheter Aortic Valve Implantation
Conditions: Aortic Valve Disease;   Myocardial Infarction;   Stroke;   Bleeding
Interventions: Drug: Aspirin + clopidogrel;   Drug: Aspirin monotherapy;   Drug: OAC + clopicogrel;   Drug: OAC monotherapy
20 Unknown  The Inhibition of Platelet Antiaggregating Activity of Clopidogrel by Atorvastatin Detected by Erythromycin Breath Test: a Metabolic Inhibition of Hepatic Cytochrome P450-3A
Conditions: Hypercholesterolemia;   Thrombosis
Interventions: Drug: Clopidogrel;   Drug: Atorvastatin

   Previous Page Studies Shown (1-20) Next Page (21-36) Show next page of results    Last Page
Indicates status has not been verified in more than two years